Literature DB >> 9345205

Hemophilic synovitis of the knee and the elbow.

E C Rodríguez-Merchán1, M Magallón, E Galindo, C López-Cabarcos.   

Abstract

A prospective study from 1974 to 1996 was done to determine optimal treatment for chronic hemophilic synovitis of the knee and synovitis of the elbow. Sixty-five patients with synovitis affecting 65 knee joints and 40 patients who had synovitis of the elbow (44 elbows), despite a 3-month trial of prophylactic substitution therapy, were treated by synovectomy. Radiation synovectomies (Au-198 synoviorthesis) were done on 38 knees, open surgical synovectomy on 18, and nine had an arthroscopic procedure. Radioactive gold synoviorthesis was performed on 29 elbows, and 15 had a resection of the radial head and partial open synovectomy. Synovectomy (by any method) significantly reduced bleeding episodes, but did not halt the radiographic deterioration of the joints. It is thought that radiation synovectomy is the best choice for patients with persistent synovitis of the knee and synovitis of the elbow unresponsive to a 3-month trial of prophylactic factor replacement. If two to three consecutive synoviortheses with 3 to 6 months intervals had been ineffective, or when the radiographic score is more than two points, an open synovectomy is indicated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345205

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

1.  Arthroscopic synovectomy in haemophilic arthropathy of the knee.

Authors:  Kyoung Ho Yoon; Dae Kyung Bae; Hee Sun Kim; Sang Jun Song
Journal:  Int Orthop       Date:  2005-08-05       Impact factor: 3.075

2.  [Orthopedic interventions in patients with hemophilia].

Authors:  Joannis Panotopoulos; Klemens Trieb
Journal:  Wien Med Wochenschr       Date:  2003

3.  Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

Authors:  Junjiang Sun; Narine Hakobyan; Leonard A Valentino; Brian L Feldman; R Jude Samulski; Paul E Monahan
Journal:  Blood       Date:  2008-08-20       Impact factor: 22.113

4.  Prevention of the musculoskeletal complications of hemophilia.

Authors:  E C Rodriguez-Merchan
Journal:  Adv Prev Med       Date:  2012-06-14

5.  Bremsstrahlung dose of therapeutic beta nuclides in bone and muscle.

Authors:  H C Manjunatha
Journal:  Indian J Nucl Med       Date:  2013-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.